Detalhe da pesquisa
1.
Efficacy, safety, and tolerability of nivasorexant in adults with binge-eating disorder: A randomized, Phase II proof of concept trial.
Int J Eat Disord
; 56(11): 2120-2130, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37584285